1. "The UK uses more monkeys than any other EU country";
2. "Animal safety tests cannot accurately predict what will happen in humans"; and 3. "The TGN1412 drug trial disaster could have been avoided using a technique known as 'micro-dosing' with spectrometry analysis".
On point 1, the NAVS said that they had taken the average numbers used in the three EU reports for 2005, 2008 and 2011, in order to avoid having the conclusion biased by its reliance on one particular report. The ASA said that, while basing the claim on the three most-recent reports was reasonable, this should have been made clear, since readers would expect the claim to be based on the most upto-date comparative figures. Hence, the ASA concluded that the NAVS had breached its rules concerning Misleading advertising, Substantiation and Qualification. With regard to point 2, the NAVS had submitted a large number of references to substantiate their claim about the value of tests on animals for predicting what will happen in humans. These included the outstanding report by the US National Research Council (NRC), Toxicity Testing in the 21st Century: A Vision and a Strategy, 4 and an authoritative article by the then Head of ECVAM (Thomas Hartung) in 2008. They also referred to two articles (presumably those by Bailey et al. in ATLA, 5,6 ), which "concluded that toxicity studies in dogs were highly inconsistent predictors of toxic responses in humans", but the ASA remarked that these, and some of the other articles referred to, had been "published in reputable peer-reviewed journals that focused on alternatives to animals research". There seemed to be an underlying assumption that articles published in "reputable medical journals" should be given more weight, but the ASA itself referred to questions raised in articles in conventional medical journals about the validity of animal tests and the reliability of the predictions they provide.
Nevertheless, while the ASA "accepted that some sections of the scientific community had questioned whether animal models were as useful in determining the efficacy and safety of new substances as generally believed", it "did not consider that the evidence provided by NAVS demonstrated that animal testing for safety had little predictive value for clinical testing". The ASA said that it "understood that it was generally accepted within the scientific community that there was value in toxicity testing on animals", and ruled that the NAVS claim had not been substantiated, so the rules concerning Misleading advertising, Substantiation and Exaggeration had been breached.
The ASA might have reached a different conclusion, had the 2014 article in the British Medical Journal by Pound and Bracken 7 been considered.
Point 3, about the TGN1412 drug trial disaster was more specific, and the statement in the NAVS advertisement summarised a highly-complicated situation. This immunomodulatory drug was a humanised monoclonal antibody, which, though tested in human volunteers at sub-clinical doses much lower than those found to be "safe" in animals, resulted in catastrophic systemic organ failure. The NAVS advertisement said that the disaster "could have been avoided" by using micro-dosing with accelerator mass spectrometry analysis. The ASA considered the evidence put forward, and admitted that the NAVS had said "could have", not "would have", but "did not consider that the evidence demonstrated that the TGN1412 drug trial disaster could have been avoided" in this way. The ASA concluded that the NAVS claim had not been substantiated, so its rules on Misleading advertising and Substantiation had been breached.
The outcome of the ASA adjudication was that the NAVS were told that the advertisement must not appear again in its current form, and that their claims that "animal safety tests cannot accurately predict what will happen in humans" and that the TGN1412 drug trial disaster could have been avoided, must not be repeated. UAR must have been delighted by this outcome.
Specific Concerns Raised by the ASA Decision
Given the blatantly misleading advertising we all have to put up with day after day, it is perhaps surprising that the ASA decision was so very tough on the NAVS.
We are all aware that statistics are frequently used in attempts to convince us of certain propositions, but the NAVS were surely right in not basing their claim about the use of non-human primates on one particular report. Saying that this should have been made more clear seems nonsensical, especially in a world where the basis for the vast majority of the claims made by advertisers is rarely readily available to those at whom they are aimed.
The second judgement was more serious. Given all the evidence, on what grounds was the ASA able to understand "that it was generally accepted within the scientific community that there was value in toxicity testing on animals"? On what evidence was the ASA's understanding based, or was that just what UAR told them? In any case, the value or other wise of animal testing was not the point made by the NAVS -their point was much more important, i.e. that "animal safety tests cannot accurately predict what will happen in humans". I submit that it is generally accepted that that statement is true.
The situation is clearly spelled out in two articles in this issue of ATLA.
Robert Coleman, 8 an independent consultant to the pharmaceutical industry, used these words: "More recently, however, the issue has become increasingly complex, with growing concern that, irrespective of ethical considerations, data generated in animal (i.e. non-human) models are not necessarily or sufficiently relevant to human patients. There is now general consensus that inter-species variability is a real issue, and that animal models are far from perfect for the purpose of ensuring either the efficacy or the safety of potential new medicines intended for human subjects."
The case against reliance on animal tests to predict efficacy and adverse effects, and the need for human cell-based organ and tissue models, is also put strongly and in detail by Tuula Heinonen, in her excellent Björn Ekwall Memorial Award Lecture, 9 where she says, inter alia, "Reliance on non-predictive tests with animal models is a major problem that has broad implications for the public, academia, human health, industry, and regu lators".
The NRC report also saw the need for substantial changes in thinking and practice in the future, summarised as follows: 10 "Advances in molecular biology, biotechnology, and other fields are paving the way for major improvements in how scientists evaluate the health risks posed by potentially toxic chemicals found at low levels in the environment. These advances would make toxicity testing quicker, less expensive, and more directly relevant to human exposures. They could also reduce the need for animal testing by substituting more laboratory tests based on human cells. This National Research Council report creates a far-reaching vision for the future of toxicity testing."
Perhaps the NAVS were unwise to include the specific case of TGN1412 in the third statement in their advertisement, as nobody could possibly have understood what they meant, without a great deal of knowledge and research. Ironically, however, this example supports, and dramatically at that, what they said about the predictive value of toxicity tests in animals in general. Also, it was in line with what Bhogal and Combes said at the time, 11 as well as with what was concluded in the Duff Report, 12 i.e. "When it is likely that pre-clinical information, for any reason, may be a poor guide to human responses in vivo, the starting doses in firstin-man trials should be calculated to err on the side of caution. Further dose increases should proceed with caution, since the initial dose may have been particularly low and there may be a steep dose-response curve." Also, I would say, since the drug had been engineered to be particularly specific and effective for humans, there should have been no surprise that tests in laboratory animals, including non-human primates, did not give sufficient warning of potential danger.
The ASA should not have given in to persuasion, on matters which those involved in the authority clearly did not fully understand or appreciate.
General Concerns Raised by the ASA Decision
The ASA ruling will soon be forgotten, even if it were ever noticed at all, but the complaint made by UAR leads to some much more important issues.
I am increasingly concerned about the tactics currently being used to promote and defend the continued reliance of so much of biomedical research and testing on the use of laboratory animals as models or surrogates for humans. For me, the ultimate questions to be faced are overwhelmingly ethical and scientific, and my own long commitment has been focused on the Three Rs concept as a means of dealing with them, although I have now come to the conclusion that we should now look beyond the Three Rs and its focus on animals, to the day when increasing humanity in biomedical research, testing and application, will have become the accepted norm for the benefit of both animals and humans. 13 I can see no place for biased, sometimes vindictive, propaganda, nor for lip-service to progress while old practices continue unabated. We have dangled before us the promises of the Concordat on Openness and its commitments, 14 but I wait to be convinced that it is a genuine attempt to maximise the application of the Three Rs. Much as I want to be convinced, I am still waiting.
The advocates of the continuing and indefinite need for animal research seem more comfortable with the adversarial approach, as in our legal system in the UK, in which two advocates represent the positions of the parties in a case, and an impartial group of people, a jury, guided by an impartial judge as a referee, attempt to determine the truth, while the advocates try to get away with their attempts to bias the selection and presentation of the evidence in favour of their clients. What should be more appropriate, when scientific facts are central to the case, is the non-adversarial, inquisitorial system, as practised in countries such as France and Italy, where the court or parts of it, attempt to determine the truth on the basis of all the available evidence, approached without bias in favour of one side or the other.
The Search for Truth
When faced with propaganda and dogma, scientists should not readily resort to counter-propaganda, but should adhere to the fundamental principles of science in documenting and publicising their search for the truth about any issue. The convention is that this requires recognising, and taking fully into account, the research, hypotheses and conclusions of other scientists. In addition to being the only way of respecting the normal courtesies of scientific progress, it is essential, in these particular circumstances, to proper adherence to the laws and regulations on animal experimentation, such as Directive 2010/63/EU and the Animals (Scientific Procedures) Act 1986. Referring only to work which supports one's own position, while ignoring that which goes against it, is not an acceptable option.
As I have said before, 14 transparency and openness alone are not enough. There must also be meaningful discussions between those who hold diametrically opposed views, but are willing to listen to the other side and either to be convinced or look for compromises. I regularly took part in such discussions in more than 50 ECVAM workshops. The workshops ran for five days, with the aim of reaching consensus and publishing a report. Day one was always characterised by suspicion and even overt hostility, which had evaporated by day five, by which time a set of conclusions and recommendations had been agreed and the participants departed with a sense of accomplishment, often accompanied by a degree of surprise. This sometimes meant staying up all night between days four and five, but it was worth it.
"The Truth Shall Make You Free"
These words of Jesus were said in a particular context, but they have been used as a motto by many academic institutions, especially in the USA, 15 where they are also carved in stone on the original headquarters building of the Central Intelligence Agency! 16 The crucial question is what is meant by 'truth', and this has troubled philosophers for thousands of years. It also troubled Pontius Pilate, when Jesus was brought before him in the events leading to the crucifixion. Jesus said, "I have come into the world to testify to the truth", and Pilate asked, "What is truth?" 17 This has led to much controversy among scholars. Was Pilate's question mocking, or rhetorical, or did it reflect the philosophical problem that truth is hard to define or to ascertain, so there is no simple answer to it.
I will resist the temptation to embark on a lengthy discussion of the nature of truth, or on its denial, manipulation or avoidance, all of which are undoubtedly highly relevant to crucial issues related to animal experimentation in general, and to the ASA ruling in particular, which, at least in my opinion, paid only scant regard to the truth.
Instead, I will make the point that both antivivisectionists and the defenders of research and testing involving laboratory animals could be freed from their current failures by turning from bias and propaganda toward truth (defined here as "in accordance with fact and reality"), especially if they embarked on a search for it together. I feel able to say this, because neither of the groups of combatants are being successful at the moment. The numbers of laboratory animals used are not falling significantly, 18 and the replacement of their use by non-animal procedures is painfully slow. 19 Meanwhile, new drugs are frequently withdrawn at very late stages in their development, and even after their acceptance for clinical use, because of the emergence of lack of effi-cacy or adverse side-effects not detected in pre-clinical testing. Also, little progress of any significance is being made in relation to serious human diseases, such as dementia, partly because of an insistence on the creation and use of inadequate animal models and a failure to invest sufficiently in clinical research. 20 and have never had, any kind of relationship with the NAVS. I did once have a meeting with them, at their premises, then in Harley Street, probably in the 1980s, after the passage of the Animals (Scientific Procedures) Act 1986, when they said that they didn't like me or FRAME and wanted nothing whatsoever to do with us. 4 
